Trial Profile

Prospective, Multicentre, Active-control Randomised Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Bleeding Adult Cardiac Surgical Patients

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prothrombin complex concentrate (Primary)
Indications Surgical blood loss
Focus Registrational; Therapeutic Use
Acronyms FARES-II
Sponsors Octapharma

Most Recent Events

02 Apr 2025 According to an Octapharma media release, data from the study were presented at the Journal of the American Medical Association (JAMA).
02 Apr 2025 Results presented in the Octapharma Media Release
31 Mar 2025 Primary endpoint (Number of patients requiring additional hemostatic intervention) has been met as per results presented in the Octapharma Media Release

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com